Autos and pharma shares dragged down fairness benchmark indices that fell for the fourth straight session on Friday logging weekly losses, on persistent considerations over US tariffs and relentless promoting by FPIs. Auto shares have been weighed down by considerations over slowing demand whereas pharma shares have been hit by prospects of tariffs on the sector.
The BSE Sensex closed down 424.90 factors or 0.56 per cent at 75,311.06, whereas the NSE Nifty 50 declined 117.25 factors or 0.51 per cent to finish at 22,795.90, marking its lowest shut in 2025.
“The home market continued to exhibit broad-based weak spot, primarily influenced by investor considerations over the hawkish tone of the FOMC minutes, which signalled extended increased rates of interest that might constrain liquidity in EMs,” mentioned Vinod Nair, Head of Analysis at Geojit Monetary Companies.
Mahindra & Mahindra led the losses within the Nifty50, tumbling 6.20 per cent, whereas Tata Motors fell over 2.5 per cent. Experiences of the federal government planning to slash import duties on electrical autos to fifteen per cent from 110 per cent forward of the entry of Tesla additionally dented sentiments towards the sector.
Pharma shares resembling Solar Prescription drugs, Dr Reddy’s Laboratories and Cipla noticed losses within the vary 0.5-1.9 per cent.
Amongst sectoral indices the Nifty Auto noticed the steepest fall at 2.6 per cent, whereas the Nifty Pharma fell 1.9 per cent. Pharma shares have borne the brunt of promoting with US President Donald Trump saying he meant to impose 25 per cent tariffs on the sector. The US market accounts for over 30 per cent of Indian pharma exports.
Different main decliners included Adani Ports, BPCL and Adani Enterprises.
Metallic shares bucked the development pushed by optimism over potential tariffs geared toward defending home producers from China’s dumping practices and higher earnings.
Overseas institutional buyers (FIIs) remained web sellers, offloading ₹33,527.55 crores value of Indian equities in February thus far. “Markets remained downbeat amid continued uncertainty on home progress, additional exacerbated by threats of reciprocal tariffs,” mentioned Shrikant Chouhan, Head of Fairness Analysis at Kotak Securities.
The broader market indices underperformed the benchmarks, with the Nifty Midcap Choose falling 1.69 per cent and Nifty Financial institution declining 0.72 per cent.
